3D Global Biotech (ROCO:6808) Long-Term Capital Lease Obligation : NT$4.08 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Long-Term Capital Lease Obligation?

3D Global Biotech's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$4.08 Mil.

3D Global Biotech's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (NT$10.38 Mil) to Jun. 2023 (NT$7.12 Mil) and declined from Jun. 2023 (NT$7.12 Mil) to Dec. 2023 (NT$4.08 Mil).

3D Global Biotech's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (NT$15.81 Mil) to Dec. 2022 (NT$10.38 Mil) and declined from Dec. 2022 (NT$10.38 Mil) to Dec. 2023 (NT$4.08 Mil).

3D Global Biotech Long-Term Capital Lease Obligation Historical Data

The historical data trend for 3D Global Biotech's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Long-Term Capital Lease Obligation Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

16.70

15.81

10.38

4.08

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial							15.81	14.17	10.38	7.12	4.08

3D Global Biotech (ROCO:6808) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

3D Global Biotech Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech (ROCO:6808) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines